Veterinary Medicines

IMIZOL 85 mg/mL, otopina za injekciju za goveda, konje i pse

Authorised
  • Imidocarb
Download as PDF

Product identification

Medicine name:
IMIZOL 85 mg/mL, otopina za injekciju za goveda, konje i pse
Active substance:
  • Imidocarb
Target species:
  • Horse (non food-producing)
  • Cattle
  • Dog
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Imidocarb
    85.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse (non food-producing)
  • Subcutaneous use
    • Cattle
      • Meat
        213
        day
      • Milk
        6
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AE01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V. Subsidiary In The Republic Of Croatia
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vet Pharma Friesoythe GmbH
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/22-01/306
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 1/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."